Department of Medicine, University of Texas Health Science Center, 11037 US Highway 271, Tyler, TX 75708, USA.
Department of Medicine, University of Texas Health Science Center, 11037 US Highway 271, Tyler, TX 75708, USA.
Clin Chest Med. 2015 Mar;36(1):79-90. doi: 10.1016/j.ccm.2014.10.005. Epub 2014 Nov 6.
The most common nontuberculous mycobacterial (NTM) lung pathogen, Mycobacterium avium complex (MAC), requires antibiotic treatment regimens that are long and often arduous. M kansasii is the slowly growing NTM pathogen with the most predictably successful treatment outcomes, whereas other slowly growing NTM pathogens such as M xeonpi, M szulgai, and M malmoense are less predictably responsive to antibiotic regimens. M simiae is the most difficult of the common slowly growing NTM pathogens to eradicate. Surgical intervention for slowly growing mycobacterial lung infection has proved beneficial for some patients, but the optimal candidates and timing for surgical intervention remain unknown.
最常见的非结核分枝杆菌(NTM)肺部病原体是鸟分枝杆菌复合群(MAC),需要采用长期且往往艰巨的抗生素治疗方案。堪萨斯分枝杆菌是生长缓慢的 NTM 病原体,其治疗效果最可预测,而其他生长缓慢的 NTM 病原体,如 M. xenopi、M. szulgai 和 M. malmoense,对抗生素治疗方案的反应则较难预测。M. simiae 是最难以根除的常见生长缓慢的 NTM 病原体之一。手术干预用于治疗生长缓慢的分枝杆菌肺部感染已被证明对某些患者有益,但手术干预的最佳候选者和时机仍不清楚。